from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3189/-

LFCtreatmentdescriptionclass of inhibitor

1.442

Amikacinug/mL Amikacintranslation

1.277

Cap5-10ug/mL Capreomycintranslation

1.850

Rox10-50 ug/mL Roxithromycintranslation

0.983

SM2-5 ug/mL Streptomycintranslation

2.799

Tet5-10 ug/mL Tetracyclinetranslation

-0.385

Rif0.2-5ug/mL Rifampicintranscription

-0.093

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.483

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.255

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.491

CPZ10-50 ug/mL Chlorpromazinerespiration

0.569

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.366

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.874

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.788

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.447

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.040

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.514

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.091

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.333

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.822

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.483

KCN5-20 ug/mL Potassium cyaniderespiration

-0.003

NaN30.2-2 mM Sodium aziderespiration

-0.096

Nigericin50 uM Nigericinrespiration

0.056

TRC10-150 ug/mL Triclosanrespiration

0.193

TRZ10-25 ug/mL Thioridazinerespiration

1.919

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.480

menadione6-10 ug/mL Menadionerespiration

-0.052

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.215

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.321

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.097

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.802

NRP_1Non-replicating persistence stage 1dosRassociated

-0.521

Amp0.2mg/mL AmpicillincellWall

-0.352

Cephalexin20-100 ug/mL CephalexincellWall

-0.074

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.404

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.310

EMB10-20 ug/mL EthambutolcellWall

-0.114

Eta12-40 ug/mL EthionamidecellWall

-0.564

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.357

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.427

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.217

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.189

BZA0.12 mg/mL BenzamidearomaticAmides

0.000

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.283

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.497

H2O24 mM hydrogen peroxideDNAdamaging

-0.318

Levo10 ug/mL LevofloxacinDNAdamaging

-0.338

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.447

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.149

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.377

UVUV-irradiationDNAdamaging

-0.813

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.726

Antimycin12.5-50 ug/mL Antimycin A?

-0.152

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.514

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.494

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.078

PA8240.2-2 ug/mL PA-824?

0.925

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.024

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.283

Verapamil50 uM Verapamil?

-0.277

mercaptoethanol2 mM 2-Mercaptoethanol?

0.040

methoxatin10-20 ug/mL Methoxatin?